How severe is CVE-2023-38950?

CVE-2023-38950 has a CVSS 3.1 base score of 7.5 (HIGH). EPSS estimates a 92.5% probability of exploitation in the next 30 days. It is listed in the CISA Known Exploited Vulnerabilities catalog.

CVE-2023-38950: ZKTeco BioTime Path Traversal

CISA Known Exploited Vulnerabilities

ZKTeco BioTime Path Traversal Vulnerability is confirmed as actively exploited and is listed in the CISA KEV catalog.

Added to KEV

2025-05-19

Remediation due

2025-06-09

Required action
Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

CISA notes
https://www.zkteco.com/en/Security_Bulletinsibs ; https://nvd.nist.gov/vuln/detail/CVE-2023-38950

Description

A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.

Severity

CVSS 3.1 · CISA7.5 HIGH

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

SSVC · CISA-ADP

Exploitationactive

Automatableyes

Technical impactpartial

Affected Products

Vendor	Product	Affected versions
-	-	n/a

References

1 Links

Other references

https://claroty.com/team82/disclosure-dashboard/cve-2023-38950

Record Details

Published

2023-08-03

Last updated

2026-07-09

Assigner (CNA)

mitre

Credited to

CVE record data © The MITRE Corporation, used under the CVE Terms of Use. Exploited-in-the-wild data from the CISA Known Exploited Vulnerabilities catalog (CC0). Exploit prediction scores by FIRST EPSS (first.org/epss). This site is not endorsed or certified by MITRE, NVD, CISA, or FIRST.